Provided by Tiger Fintech (Singapore) Pte. Ltd.

Twist Bioscience Corp

39.68
+2.576.93%
Post-market: 39.680.00000.00%19:37 EST
Volume:2.70M
Turnover:103.40M
Market Cap:2.37B
PE:-11.75
High:40.84
Open:36.00
Low:34.35
Close:37.11
Loading ...

Company Profile

Company Name:
Twist Bioscience Corp
Exchange:
NASDAQ
Establishment Date:
2013
Employees:
923
Office Location:
681 Gateway Boulevard,South San Francisco,California,United States
Zip Code:
94080
Fax:
- -
Introduction:
Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Directors

Name
Position
Emily M. Leproust
Chief Executive Officer and Board Chair
Robert B. Chess
Lead Independent Director
William Banyai
Senior Vice President of Advanced Development, General Manager of Data Storage and Director
Jan Johannessen
Director
Keith Crandell
Director
Melissa A. Starovasnik
Director
Nelson C. Chan
Director
Robert Ragusa
Director
Xiaoying Mai
Director

Shareholders

Name
Position
Emily M. Leproust
Chief Executive Officer and Board Chair
Patrick Finn
President and Chief Operating Officer
Dennis Cho
Senior Vice President, General Counsel, Secretary and Chief Ethics and Compliance Officer
James M. Thorburn
Chief Financial Officer
Paula Green
Senior Vice President of Human Resources
Robert Werner
Chief Accounting Officer